Vivus (VVUS)

VVUS (NASDAQ:Drugs)
$3.38
pos +0.06
+1.78%
Today's Range: 3.32 - 3.45 | VVUS Avg Daily Volume: 2,223,600
Last Update: 10/23/14 - 12:26 PM EDT
Volume: 439,699
YTD Performance: -63.44%
Open: $3.38
Previous Close: $3.32
52 Week Range: $3.13 - $10.29
Oustanding Shares: 103,460,015
Market Cap: 359,006,252
6-Month Chart
TheStreet Ratings Grade for VVUS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 3 4
Moderate Sell 2 2 2 2
Strong Sell 2 2 2 2
Mean Rec. 4.00 3.57 3.50 3.44
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -3.34
Price Earnings Comparisons:
VVUS Sector Avg. S&P 500
-3.34 0.00 28.03
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-30.11% -64.90% -61.66%
GROWTH 12 Mo 3 Yr CAGR
Revenue 3,929.90 0.00 0.00
Net Income 0.00 1.32 0.00
EPS 0.00 1.10 0.00
Earnings for VVUS:
EBITDA -0.11B
Revenue 0.08B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $-0.21 $-0.28 $-1.06 $-1.25
Number of Analysts 4 3 6 6
High Estimate $-0.07 $-0.24 $-0.74 $-0.83
Low Estimate $-0.45 $-0.32 $-1.52 $-2.13
Prior Year $-0.48 $-0.12 $-1.51 $-1.06
Growth Rate (Year over Year) 55.73% -130.56% 29.91% -17.95%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Christopher Versace

 | Dec 24, 2013 | 10:30 AM EST

Time to examine a couple that didn't pan out.

bearishVivus downgraded at Piper Jaffray

Oct 16, 2013 | 8:52 AM EDT

VVUS was downgraded to Neutral from Overweight, according to Piper Jaffray. Headwind from increased competition and lack of partnership for product deployment. $11 price target and Neutral rating.

By

Gary Berman

 | Oct 3, 2013 | 10:53 AM EDT

The short-term picture has changed.

By

Gary Berman

 | Oct 2, 2013 | 11:28 AM EDT

This looks ready to make a move higher.

By

Tim Melvin

 | Sep 23, 2013 | 2:00 PM EDT

Some of the market's favorite stocks have entered a danger zone.

bearishVivus downgraded at Lazard

Sep 4, 2013 | 7:33 AM EDT

VVUS was downgraded to Sell, Lazard Capital Markets said. $8 price target. Qsymia has had a slow launch and the company's patents could face competition.

bearishVivus estimates lowered at Jefferies

Aug 7, 2013 | 7:44 AM EDT

VVUS estimates lowered through 2013, Jefferies said. $5 price target. Weak 2Q but signs of acceleration in 3Q. Underperform rating. 

bearishVivus cut from US 1 List at BofA/Merrill

Jul 23, 2013 | 8:15 AM EDT

VVUS was removed from the US1 list, according to Bank of America/Merrill Lynch. An inflection in Qsymia prescriptions could take time. $22 price target. 

By

Christopher Versace

 | Jul 11, 2013 | 9:00 AM EDT

Liquidity is key, and one ETF stands above the rest.

By

Christopher Versace

 | Jul 10, 2013 | 9:30 AM EDT

Obesity costs are a  pain point, which  often create good investments.

Big spread in the small cap index. With RUT up 22.40 to 1111.90, the expiring Weekly (10/2...
Shares of Waste Management are trading at fresh 52 week highs this morning. The sto...
Market is off to a great start after yesterday's decline. Solid earnings from Caterpillar...
With the SPX trading in 1% moves per day VIX feels priced right around 16. For now the se...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.